Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adult Hepatocellular Carcinoma
|
14 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Adult Hodgkin Lymphoma
|
27 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
ANOPHTHALMIA AND PULMONARY HYPOPLASIA
|
80 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||
BREAST AND COLORECTAL CANCER, SUSCEPTIBILITY TO
|
7 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.700 | 0 | ||||||||
BREAST CANCER, SUSCEPTIBILITY TO
|
24 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.700 | 0 | ||||||||
Breast Carcinoma
|
2793 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.900 | 0.895 | 19 | 2003 | 2017 | |||||
CANCER OF MULTIPLE TYPES, SUSCEPTIBILITY TO
|
1 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.700 | 0 | ||||||||
Carcinoma of lung
|
1204 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.730 | 1.000 | 4 | 2008 | 2016 | |||||
Carcinoma, Lobular
|
1 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.010 | 1 | 2005 | 2005 | ||||||
Childhood Hepatocellular Carcinoma
|
17 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Childhood Hodgkin Lymphoma
|
29 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Colon Carcinoma
|
275 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.010 | 1.000 | 1 | 2004 | 2004 | |||||
COLORECTAL CANCER, SUSCEPTIBILITY TO
|
8 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.700 | 0 | ||||||||
Colorectal Carcinoma
|
1962 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.090 | 0.889 | 9 | 2006 | 2013 | |||||
Cystadenoma
|
1 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.010 | 1.000 | 1 | 2006 | 2006 | |||||
Differentiated Thyroid Gland Carcinoma
|
80 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.010 | 1 | 2014 | 2014 | ||||||
Endometrial Carcinoma
|
326 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.710 | 1.000 | 1 | 2009 | 2009 | |||||
Familial (FPAH)
|
276 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.030 | 1.000 | 3 | 2006 | 2019 | |||||
Hereditary pancreatitis
|
108 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.010 | 1.000 | 1 | 2003 | 2003 | |||||
Hodgkin Disease
|
148 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.010 | 1.000 | 1 | 2011 | 2011 | |||||
Li-Fraumeni Syndrome 2
|
11 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.700 | 0 | ||||||||
Liver carcinoma
|
942 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.010 | 1 | 2013 | 2013 | ||||||
Luminal A Breast Carcinoma
|
11 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||
Malignant neoplasm of breast
|
3417 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.800 | 0.929 | 28 | 2001 | 2016 | |||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.597 | 0.480 | 22 | 28725099 | missense variant | A/C;G | snv | 4.1E-03 | 0.070 | 1.000 | 7 | 2006 | 2013 |